Entecavir Is Well Tolerated For The Treatment Of Nucleoside-Naive And Lamivudine-Refractory Chronic Hepatitis B: Phase 2/3 Safety ResultsRg Gish,M Sherman,As Lok,Pj Pockros,M Raptopoulou-Gigi, Jd Sollano,Tt Chang,E Cooney, Rg Hindes, Jy Yang,Ap Cross,Rb WilberLIVER INTERNATIONAL(2005)引用 0|浏览14暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要